Concord Drugs Limited has submitted a regulatory intimation to BSE Limited regarding an upcoming Board of Directors meeting. The meeting is scheduled to be held on Thursday, 12th November 2026 at the company's registered office located at Survey No. 249, Brahmanapally Village, Hayathnagar Mandal, R.R. Dist. - 501 511, Telangana, India.
The primary agenda for the board meeting is to consider and approve the un-audited financial results for the quarter ended 30th September 2026, covering both standalone and consolidated financial statements. The board may also transact other business as considered necessary with the permission of the chair.
In accordance with the company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the company's equity shares has been closed for all designated persons and their immediate relatives. The trading window closure is effective from the date of this intimation and will remain closed until 48 hours after the declaration of the financial results.